
Opinion|Videos|September 20, 2024
AI and the Future of Biomarkers in Prostate Cancer
Prostate cancer specialists share their insights on anticipated future advancements that could significantly influence prostate cancer management strategies.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What future advancements in testing protocols do you anticipate, and how might they impact the management of prostate cancer?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5























